Advertisement

Topics

A hit and a miss for Daiichi Sankyo's pain drug

04:39 EDT 5 Jul 2017 | BioPharmaDive

Mirogabalin hit its mark in post-herpetic neuralgia, but three other late-stage studies in fibromyalgia pain came up short. 

Original Article: A hit and a miss for Daiichi Sankyo's pain drug

NEXT ARTICLE

More From BioPortfolio on "A hit and a miss for Daiichi Sankyo's pain drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...